Lb Pharmaceuticals (LBRX) Amortizatization of Intangibles (2024 - 2026)
Lb Pharmaceuticals (LBRX) posted quarterly Amortizatization of Intangibles of -$17000.0 for Q1 2026, down 241.67% year-over-year from $12000.0 in Q1 2025, and little changed quarter-over-quarter from -$17000.0 in Q4 2025.
Powered by 
Analysis
Lb Pharmaceuticals (LBRX) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Lb Pharmaceuticals' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at -$17000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 241.67% year-over-year to -$17000.0; the TTM figure through Mar 2026 stood at $39000.0 (changed N/A YoY), while the FY2025 annual figure was -$261000.0, down 867.65% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at -$17000.0, roughly flat from -$17000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $61000.0 in Q4 2024, with the low at -$17000.0 in Q4 2025.
- The 3-year median for Amortizatization of Intangibles is -$2500.0 (2025), against an average of $9750.0.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles slumped 127.87% in 2025, then slumped 241.67% in 2026.
- Lb Pharmaceuticals' Amortizatization of Intangibles stood at $61000.0 in 2024, then plunged by 127.87% to -$17000.0 in 2025, then changed by 0.0% to -$17000.0 in 2026.
- Business Quant data shows LBRX's Amortizatization of Intangibles at -$17000.0 in Q1 2026, -$17000.0 in Q4 2025, and $12000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Lb Pharmaceuticals | 1.49 Bn | 1.49 Bn | - | 70,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Sep 30, 2025 | -256,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 61,000.00 |